AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
18 hedge funds and large institutions have $40.7M invested in Ambrx Biopharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
1
Reduced
8
Closed
4
Calls
$61K
Puts
$233K
Net Calls
-$172K
Net Calls Change
-$172K